Back
Achilles Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
27
ACHL
Achilles Therapeutics PLC
Last Price:
0.98
Seasonality Move:
-13.23%
Sell
32
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.59
Seasonality Move:
29.16%
Sell
27
Achilles Therapeutics PLC (ACHL)
is a Sell
Is Achilles Therapeutics PLC a Buy, Sell or Hold?
- The current Achilles Therapeutics PLC [ACHL] share price is $0.99. The Score for ACHL is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ACHL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.58. The Score for ADAP is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACHL Stock Price Chart
What is Achilles Therapeutics PLC's stock price today?
-
The Achilles Therapeutics PLC share price today is $0.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACHL is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
ACHL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 34.41 | Sell |
| Chaikin Money Flow: | 87042 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.07) | Sell |
| Bollinger Bands (100): | (0.77 - 1.05) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 32.52 | Sell |
| Chaikin Money Flow: | -297165 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.61 - 0.75) | Sell |
| Bollinger Bands (100): | (0.72 - 1.14) | Sell |
ACHL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.03 | Sell |
| 20-day SMA: | 1.05 | Sell |
| 50-day SMA: | 1.03 | Sell |
| 200-day SMA: | 0.93 | Buy |
| 8-day EMA: | 1.02 | Sell |
| 20-day EMA: | 1.04 | Sell |
| 50-day EMA: | 1.01 | Sell |
| 200-day EMA: | 0.95 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.64 | Sell |
| 20-day SMA: | 0.66 | Sell |
| 50-day SMA: | 0.75 | Sell |
| 200-day SMA: | 1.06 | Sell |
| 8-day EMA: | 0.63 | Sell |
| 20-day EMA: | 0.67 | Sell |
| 50-day EMA: | 0.76 | Sell |
| 200-day EMA: | 0.95 | Sell |
Achilles Therapeutics PLC Earnings Growth & ACHL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.12 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.
Achilles Therapeutics PLC Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||